Fifth Third Bancorp
SGNT

Fifth Third Bancorp’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Fifth Third Bancorp’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,290
Closed -$28K – 2420
2016
Q1 		$28K Buy
2,290
+2,223
+3,318% +$31.2K ﹤0.01% 1526
2015
Q4 		$1K Buy
67
+1
+2% +$16 ﹤0.01% 2706
2015
Q3 		$1K Buy
66
+25
+61% +$540 ﹤0.01% 2860
2015
Q2 		$1K Buy
41
+1
+3% +$24 ﹤0.01% 2837
2015
Q1 		$1K Sell
40
-4,960
-99% -$131K ﹤0.01% 2744
2014
Q4 		$126K Buy
5,000
+500
+11% +$14.7K ﹤0.01% 1087
2014
Q3 		$140K Hold
4,500
– – ﹤0.01% 1064
2014
Q2 		$116K Hold
4,500
– – ﹤0.01% 1133
2014
Q1 		$105K Hold
4,500
– – ﹤0.01% 1156
2013
Q4 		$114K Buy
+4,500
New +$102K ﹤0.01% 1058

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fifth Third Bancorp's SGNT Position: Q2 2016 in Review

Fifth Third Bancorp sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 2,290 shares — an estimated $28K sold.

Fifth Third Bancorp first reported a position in SGNT in Q4 2013 and held it in 10 quarters. The position peaked at $140K in Q3 2014. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Fifth Third Bancorp reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Fifth Third Bancorp sold 2,290 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $28K.
  • Fifth Third Bancorp first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 10 quarters.
  • Fifth Third Bancorp's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $140K in Q3 2014.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Fifth Third Bancorp's 13F filing for Q2 2016, filed 11 Aug 2016.